<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62042">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01863836</url>
  </required_header>
  <id_info>
    <org_study_id>IUCPQ-20913</org_study_id>
    <nct_id>NCT01863836</nct_id>
  </id_info>
  <brief_title>Study on the Influence of Fluoroscopy in the Diagnosis of Peripheral Lung Lesions With Endobronchial Ultrasound Guidance</brief_title>
  <official_title>Randomized Trial of Fluoroscopy Use for Radial Endobronchial Ultrasound-guided Biopsy of Peripheral Lung Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <authority>Canada: Comité d'éthique de la recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of fluoroscopy improves the
      diagnostic yield of peripheral pulmonary lesions' biopsy guided by radial endobronchial
      ultrasound (with the use of a guide sheath).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>Upon production of pathology results, usually within 2 weeks after the test</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diagnostic yield of radial endobronchial ultrasound-guided biopsy for peripheral lung lesions defined as the proportion of patients in whom a specific diagnosis is established by radial endobronchial ultrasound-guided biopsy. The analysis will be stratified by lesion size, location, the presence of the bronchus sign, type of echographic image obtained (central/peripheral), physician involved, resident involvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity and specificity</measure>
    <time_frame>Upon completion of ancillary or confirmatory tests, usually within 2 months after the test</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sensitivity and specificity are determined separately for malignancy and benign etiologies. Case records will be reviewed for patients with non-diagnostic specimen and results from other diagnostic procedures (TTNA, surgical biopsy) will be reviewed. For patients without further diagnostic tests, stability or progression of the lesion over time will be used for etiology attribution.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lesion localization</measure>
    <time_frame>Immediate (during the test)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of patients in whom the peripheral pulmonary lesion was localized using the radial endobronchial ultrasound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration</measure>
    <time_frame>During the test</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total duration of the bronchoscopic test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Immediately during the test and up to 4 hours after the test</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>occurrence of pneumothorax (and its management), bleeding more than 50ml, sustained desaturation below 90%, cardiac dysrhythmias, or any other adverse events occuring during or after the procedure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Peripheral Pulmonary Lesions</condition>
  <arm_group>
    <arm_group_label>Fluoroscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo bronchoscopy and radial endobronchial ultrasound-guided biopsy of a peripheral lung lesion like patients in the other group. However, single-plane fluoroscopy will be used to help locate the lesion (with the help of a steerable curette) in case of failure to locate the lesion, and it will also be used to guide tissue sampling and ensure appropriate sampling tool function. Transbronchial biopsies, transbronchial needle aspiration, brushings, and bronchoalveolar lavage will be performed for each lesion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No fluoroscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo biopsy of peripheral lung lesions using radial endobronchial ultrasound guidance only, without the use of fluoroscopy. Transbronchial biopsies, transbronchial needle aspiration, brushings, and bronchoalveolar lavage will be performed for each lesion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluoroscopy</intervention_name>
    <arm_group_label>Fluoroscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radial endobronchial ultrasound-guided biopsy (with the use of a guide sheath)</intervention_name>
    <arm_group_label>Fluoroscopy</arm_group_label>
    <arm_group_label>No fluoroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients referred for the bronchoscopic diagnosis of peripheral pulmonary
             lesions at the Institut Universitaire de Cardiologie et de Pneumologie de Québec(not
             visible endobronchially)

          -  Adults over the age of 18

        Exclusion Criteria:

          -  Therapeutic anticoagulation

          -  Antiplatelet therapy other than aspirin

          -  Known hemorrhagic diathesis

          -  Acute respiratory failure

          -  Pregnancy

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine Delage, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine Delage, MD</last_name>
    <phone>418-656-8711</phone>
    <phone_ext>5144</phone_ext>
    <email>antoine.delage@criucpq.ulaval.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Beaudoin, MD</last_name>
    <phone>418-656-8711</phone>
    <phone_ext>5144</phone_ext>
    <email>stephane.beaudoin@mail.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stéphane Beaudoin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine Delage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Martel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nancy Ferland, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 23, 2013</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Antoine Delage</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Radial endobronchial ultrasound</keyword>
  <keyword>Peripheral lung lesion</keyword>
  <keyword>Fluoroscopy</keyword>
  <keyword>Lung cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
